IQVIA HOLDINGS INC. Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate
IQVIA HOLDINGS INC. (IQV) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate of 2.46% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate · last filed 2016-02-11
- IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2015 was 2.46%, a 18.27% decline from fiscal 2014.
- IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2014 was 3.01%, a 1.63% decline from fiscal 2013.
- IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2013 was 3.06%, a 7.83% decline from fiscal 2012.
- IQVIA HOLDINGS INC. defined benefit plan, assumptions used calculating net periodic benefit cost, discount rate for fiscal 2012 was 3.32%, a 9.78% decline from fiscal 2011.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate 12 month |
|---|---|
| 2015-12-31 | 2.46% 10-K · filed 2016-02-11 |
| 2014-12-31 | 3.01% 10-K · filed 2016-02-11 |
| 2013-12-31 | 3.06% 10-K · filed 2016-02-11 |
| 2012-12-31 | 3.32% 10-K · filed 2015-02-12 |
| 2011-12-31 | 3.68% 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |